Michael J McGeachie1, Ann C Wu2, Sze Man Tse3, George L Clemmer3, Joanne Sordillo3, Blanca E Himes4, Jessica Lasky-Su3, Robert P Chase3, Fernando D Martinez5, Peter Weeke6, Christian M Shaffer7, Hua Xu8, Josh C Denny7, Dan M Roden9, Reynold A Panettieri10, Benjamin A Raby3, Scott T Weiss3, Kelan G Tantisira3. 1. Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Mass. Electronic address: michael.mcgeachie@channing.harvard.edu. 2. Center for Child Health Care Studies, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Mass; Division of General Pediatrics, Department of Pediatrics, Children's Hospital, Boston, Mass. 3. Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Mass. 4. Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pa. 5. Arizona Respiratory Center, University of Arizona, Tucson, Ariz. 6. Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tenn; Department of Cardiology, Copenhagen University Hospital, Gentofte, Denmark. 7. Department of Internal Medicine, Vanderbilt University School of Medicine, Nashville, Tenn. 8. Health Science Center at Houston, University of Texas, Houston, Tex. 9. Office of Personalized Medicine, Vanderbilt University School of Medicine, Nashville, Tenn. 10. Airways Biology Initiative, University of Pennsylvania Medical Center, Philadelphia, Pa.
Abstract
BACKGROUND: Asthma exacerbations are a major cause of morbidity and medical cost. OBJECTIVE: The objective of this study was to identify genetic predictors of exacerbations in asthmatic subjects. METHODS: We performed a genome-wide association study meta-analysis of acute asthma exacerbation in 2 pediatric clinical trials: the Childhood Asthma Management Program (n = 581) and the Childhood Asthma Research and Education (n = 205) network. Acute asthma exacerbations were defined as treatment with a 5-day course of oral steroids. We obtained a replication cohort from Biobank of Vanderbilt University Medical Center (BioVU; n = 786), the Vanderbilt University electronic medical record-linked DNA biobank. We used CD4(+) lymphocyte genome-wide mRNA expression profiling to identify associations of top single nucleotide polymorphisms with mRNA abundance of nearby genes. RESULTS: A locus in catenin (cadherin-associated protein), alpha 3 (CTNNA3), reached genome-wide significance (rs7915695, P = 2.19 × 10(-8); mean exacerbations, 6.05 for minor alleles vs 3.71 for homozygous major alleles). Among the 4 top single nucleotide polymorphisms replicated in BioVU, rs993312 in Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D (SEMA3D) was significant (P = .0083) and displayed stronger association among African Americans (P = .0004 in BioVU [mean exacerbations, 3.91 vs 1.53]; P = .0089 in the Childhood Asthma Management Program [mean exacerbations, 6.0 vs 3.25]). CTNNA3 variants did not replicate in BioVU. A regulatory variant in the CTNNA3 locus was associated with CTNNA3 mRNA expression in CD4(+) cells from asthmatic patients (P = .00079). CTNNA3 appears to be active in the immune response, and SEMA3D has a plausible role in airway remodeling. We also provide a replication of a previous association of purinergic receptor P2X, ligand-gated ion channel, 7 (P2RX7), with asthma exacerbation. CONCLUSIONS: We identified 2 loci associated with exacerbations through a genome-wide association study. CTNNA3 met genome-wide significance thresholds, and SEMA3D replicated in a clinical biobank database.
BACKGROUND: Asthma exacerbations are a major cause of morbidity and medical cost. OBJECTIVE: The objective of this study was to identify genetic predictors of exacerbations in asthmatic subjects. METHODS: We performed a genome-wide association study meta-analysis of acute asthma exacerbation in 2 pediatric clinical trials: the Childhood Asthma Management Program (n = 581) and the Childhood Asthma Research and Education (n = 205) network. Acute asthma exacerbations were defined as treatment with a 5-day course of oral steroids. We obtained a replication cohort from Biobank of Vanderbilt University Medical Center (BioVU; n = 786), the Vanderbilt University electronic medical record-linked DNA biobank. We used CD4(+) lymphocyte genome-wide mRNA expression profiling to identify associations of top single nucleotide polymorphisms with mRNA abundance of nearby genes. RESULTS: A locus in catenin (cadherin-associated protein), alpha 3 (CTNNA3), reached genome-wide significance (rs7915695, P = 2.19 × 10(-8); mean exacerbations, 6.05 for minor alleles vs 3.71 for homozygous major alleles). Among the 4 top single nucleotide polymorphisms replicated in BioVU, rs993312 in Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D (SEMA3D) was significant (P = .0083) and displayed stronger association among African Americans (P = .0004 in BioVU [mean exacerbations, 3.91 vs 1.53]; P = .0089 in the Childhood Asthma Management Program [mean exacerbations, 6.0 vs 3.25]). CTNNA3 variants did not replicate in BioVU. A regulatory variant in the CTNNA3 locus was associated with CTNNA3 mRNA expression in CD4(+) cells from asthmatic patients (P = .00079). CTNNA3 appears to be active in the immune response, and SEMA3D has a plausible role in airway remodeling. We also provide a replication of a previous association of purinergic receptor P2X, ligand-gated ion channel, 7 (P2RX7), with asthma exacerbation. CONCLUSIONS: We identified 2 loci associated with exacerbations through a genome-wide association study. CTNNA3 met genome-wide significance thresholds, and SEMA3D replicated in a clinical biobank database.
Authors: Stanley Szefler; Scott Weiss; James Tonascia; N Franklin Adkinson; Bruce Bender; Reuben Cherniack; Michele Donithan; H William Kelly; Joseph Reisman; Gail G Shapiro; Alice L Sternberg; Robert Strunk; Virginia Taggart; Mark Van Natta; Robert Wise; Margaret Wu; Robert Zeiger Journal: N Engl J Med Date: 2000-10-12 Impact factor: 91.245
Authors: Theresa W Guilbert; Wayne J Morgan; Marzena Krawiec; Robert F Lemanske; Chris Sorkness; Stanley J Szefler; Gary Larsen; Joseph D Spahn; Robert S Zeiger; Gregory Heldt; Robert C Strunk; Leonard B Bacharier; Gordon R Bloomberg; Vernon M Chinchilli; Susan J Boehmer; Elizabeth A Mauger; David T Mauger; Lynn M Taussig; Fernando D Martinez Journal: Control Clin Trials Date: 2004-06
Authors: Anne Fuhlbrigge; David Peden; Andrea J Apter; Homer A Boushey; Carlos A Camargo; James Gern; Peter W Heymann; Fernando D Martinez; David Mauger; William G Teague; Carol Blaisdell Journal: J Allergy Clin Immunol Date: 2012-03 Impact factor: 10.793
Authors: Robert C Strunk; Stanley J Szefler; Brenda R Phillips; Robert S Zeiger; Vernon M Chinchilli; Gary Larsen; Kevin Hodgdon; Wayne Morgan; Christine A Sorkness; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2003-11 Impact factor: 10.793
Authors: B Janssens; S Goossens; K Staes; B Gilbert; J van Hengel; C Colpaert; E Bruyneel; M Mareel; F van Roy Journal: J Cell Sci Date: 2001-09 Impact factor: 5.285
Authors: Blanca E Himes; Xiaofeng Jiang; Peter Wagner; Ruoxi Hu; Qiyu Wang; Barbara Klanderman; Reid M Whitaker; Qingling Duan; Jessica Lasky-Su; Christina Nikolos; William Jester; Martin Johnson; Reynold A Panettieri; Kelan G Tantisira; Scott T Weiss; Quan Lu Journal: PLoS One Date: 2014-06-13 Impact factor: 3.240
Authors: Klaus Bønnelykke; Patrick Sleiman; Kasper Nielsen; Eskil Kreiner-Møller; Josep M Mercader; Danielle Belgrave; Herman T den Dekker; Anders Husby; Astrid Sevelsted; Grissel Faura-Tellez; Li Juel Mortensen; Lavinia Paternoster; Richard Flaaten; Anne Mølgaard; David E Smart; Philip F Thomsen; Morten A Rasmussen; Silvia Bonàs-Guarch; Claus Holst; Ellen A Nohr; Rachita Yadav; Michael E March; Thomas Blicher; Peter M Lackie; Vincent W V Jaddoe; Angela Simpson; John W Holloway; Liesbeth Duijts; Adnan Custovic; Donna E Davies; David Torrents; Ramneek Gupta; Mads V Hollegaard; David M Hougaard; Hakon Hakonarson; Hans Bisgaard Journal: Nat Genet Date: 2013-11-17 Impact factor: 38.330
Authors: Amber Dahlin; Joanne E Sordillo; John Ziniti; Carlos Iribarren; Meng Lu; Scott T Weiss; Kelan G Tantisira; Quan Lu; Mengyuan Kan; Blanca E Himes; Eric Jorgenson; Ann Chen Wu Journal: J Allergy Clin Immunol Date: 2018-12-20 Impact factor: 10.793
Authors: Stephen Sai Folmsbee; G R Scott Budinger; Paul J Bryce; Cara J Gottardi Journal: J Allergy Clin Immunol Date: 2016-03-03 Impact factor: 10.793
Authors: Michael J McGeachie; George L Clemmer; Boris Hayete; Heming Xing; Karl Runge; Ann Chen Wu; Xiaofeng Jiang; Quan Lu; Bruce Church; Iya Khalil; Kelan Tantisira; Scott Weiss Journal: J Allergy Clin Immunol Date: 2018-03-02 Impact factor: 10.793
Authors: Qi Yan; Erick Forno; Esther Herrera-Luis; Maria Pino-Yanes; Cancan Qi; Raimon Rios; Yueh-Ying Han; Soyeon Kim; Sam Oh; Edna Acosta-Pérez; Rong Zhang; Donglei Hu; Celeste Eng; Scott Huntsman; Lydiana Avila; Nadia Boutaoui; Michelle M Cloutier; Manuel E Soto-Quiros; Cheng-Jian Xu; Scott T Weiss; Jessica Lasky-Su; Megan R Kiedrowski; Camila Figueiredo; Jennifer Bomberger; Mauricio L Barreto; Glorisa Canino; Wei Chen; Gerard H Koppelman; Esteban G Burchard; Juan C Celedón Journal: Eur Respir J Date: 2021-04-01 Impact factor: 16.671